A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families

被引：0

作者：

A M Goldstein

L Liu

M G Shennan

D Hogg

M A Tucker

J P Struewing

机构：

[1] National Cancer Institute,Division of Cancer Epidemiology and Genetics

[2] The University of Toronto,Department of Medicine

[3] Toronto-Sunnybrook Regional Cancer Centre,Division of Medical Oncology

[4] The University of Toronto,Department of Medical Biophysics

来源：

British Journal of Cancer | 2001年 / 85卷

关键词：

melanoma; V126D; founder;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

One of the most common melanoma-related CDKN2A mutations reported in North America is the V126D mutation. We examined nine markers surrounding CDKN2A in three American and four Canadian families carrying the V126D mutation. All seven families had a haplotype consistent with a common ancestor/founder for this mutation. In addition, the mutation appears to have originated 34–52 generations ago (1-LOD-unit support interval 13–98 generations). © 2001 Cancer Research Campaign http://www.bjcancer.com

引用

页码：527 / 530

页数：3

共 50 条

[31] Functional, Structural, and Genetic Evaluation of 20 CDKN2A Germ Line Mutations Identified in Melanoma-Prone Families or Patients
Kannengiesser, Caroline
Brookes, Sharon
del Arroyo, Anna Gutierrez
Pham, Danielle
Bombled, Johny
Barrois, Michel
Mauffret, Olivier
Avril M, Marie-Francoise
Chompret, Agnes
Lenoir, Gilbert M.
Sarasin, Alain
Peters, Gordon
Bressac-de Paillerets, Brigitte
HUMAN MUTATION, 2009, 30 (04) : 564 - 574
[32] Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families
Sargen, Michael R.
Pfeiffer, Ruth M.
Yang, Xiaohong R.
Tucker, Margaret A.
Goldstein, Alisa M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (01) : 174 - +
[33] Mutation analysis of the cdkn2a promoter in australian melanoma families
Pollock P.A.
Stark M.
Palmer J.M.
Walters M.K.
Martin N.G.
Green A.C.
Hayward N.K.
Nature Genetics, 2001, 27 (Suppl 4) : 80 - 80
[34] Mutation analysis of the CDKN2A promoter in Australian melanoma families
Pollock, PM
Stark, MS
Palmer, JM
Walters, MK
Aitken, JF
Martin, NG
Hayward, NK
GENES CHROMOSOMES & CANCER, 2001, 32 (01): : 89 - 94
[35] CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations
Pissa, Maria
Helkkula, Teo
Appelqvist, Frida
Silander, Gustav
Borg, Ake
Pettersson, Jenny
Lapins, Jan
Nielsen, Kari
Hoiom, Veronica
Helgadottir, Hildur
ACTA ONCOLOGICA, 2021, 60 (07) : 888 - 896
[36] Association Of Genetic Variants With The Risk Of Dysplastic Nevi In Melanoma-Prone Families With And Without CDKN2A/CDK4 Mutations
Liang, Xueying
Pfeiffer, Ruth M.
Wheeler, William
Maeder, Dennis
Burdette, Laurie
Meredith, Yeager
Chanock, Stephen
Margaret, Tucker A.
Goldstein, Alisa M.
Yang, Xiaohong R.
GENETIC EPIDEMIOLOGY, 2012, 36 (02) : 128 - 128
[37] Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families
Hashemi, J
Bendahl, PO
Sandberg, T
Platz, A
Linder, S
Stierner, U
Olsson, H
Ingvar, C
Hansson, J
Borg, A
GENES CHROMOSOMES & CANCER, 2001, 31 (02): : 107 - 116
[38] Germline variants in CDKN2A wild-type melanoma prone families
Knappskog, Stian
Iversen, Gjertrud T.
Loeng, Marie
Holth, Amalie L.
Lonning, Per E.
Geisler, Jurgen
CANCER RESEARCH, 2024, 84 (06)
[39] Germline variants in CDKN2A wild-type melanoma prone families
Iversen, Gjertrud T.
Loeng, Marie
Holth, Amalie Lund
Lonning, Per E.
Geisler, Jurgen
Knappskog, Stian
MOLECULAR ONCOLOGY, 2025,
[40] Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations
Xiaohong Rose Yang
Xueying Liang
Ruth M. Pfeiffer
William Wheeler
Dennis Maeder
Laurie Burdette
Meredith Yeager
Stephen Chanock
Margaret A. Tucker
Alisa M. Goldstein
Familial Cancer, 2010, 9 : 625 - 633

← 1 2 3 4 5 →